175 related articles for article (PubMed ID: 29860455)
1. Anti-CD160, Alone or in Combination With Bevacizumab, Is a Potent Inhibitor of Ocular Neovascularization in Rabbit and Monkey Models.
Menguy T; Briaux A; Jeunesse E; Giustiniani J; Calcei A; Guyon T; Mizrahi J; Haegel H; Duong V; Soler V; Brousset P; Bensussan A; Raymond Letron I; Le Bouteiller P
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2687-2698. PubMed ID: 29860455
[TBL] [Abstract][Full Text] [Related]
2. Comparing The Efficacy Of An Anti-Human VEGF-A Neutralizing Antibody Versus Bevacizumab On A Laser-Induced Choroidal Neovascularization (CNV) Rhesus Monkey Model.
Olvera-Montaño O; Baiza-Duran L; Quintana-Hau JD; Quiñonez-Alvarado MG; Zeng W; Gong L; Muñoz-Villegas P
Drug Des Devel Ther; 2019; 13():3813-3821. PubMed ID: 31806932
[TBL] [Abstract][Full Text] [Related]
3. Repeated retinal photocoagulation in monkeys for the optimization of a laser-induced choroidal neovascularization model.
Lin X; Wang Q; He M
Exp Eye Res; 2019 Jul; 184():1-7. PubMed ID: 30928489
[TBL] [Abstract][Full Text] [Related]
4. Anti-vascular Endothelial Growth Factor Antibody Limits the Vascular Leakage and Decreases Subretinal Fibrosis in a Cynomolgus Monkey Choroidal Neovascularization Model.
Inagaki S; Shimazawa M; Hamaguchi K; Otsu W; Araki T; Sasaki Y; Numata Y; Tsusaki H; Hara H
Curr Neurovasc Res; 2020; 17(4):420-428. PubMed ID: 32445455
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).
Costa RA; Jorge R; Calucci D; Melo LA; Cardillo JA; Scott IU
Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1273-80. PubMed ID: 17333238
[TBL] [Abstract][Full Text] [Related]
6. Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis.
Chen WL; Lin CT; Lin NT; Tu IH; Li JW; Chow LP; Liu KR; Hu FR
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1659-65. PubMed ID: 18997093
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
Retina; 2007; 27(4):432-8. PubMed ID: 17420694
[TBL] [Abstract][Full Text] [Related]
8. Optimization of laser-induced choroidal neovascularization in African green monkeys.
Goody RJ; Hu W; Shafiee A; Struharik M; Bartels S; López FJ; Lawrence MS
Exp Eye Res; 2011 Jun; 92(6):464-72. PubMed ID: 21414311
[TBL] [Abstract][Full Text] [Related]
9. Relative contribution of VEGF and TNF-alpha in the cynomolgus laser-induced CNV model: comparing the efficacy of bevacizumab, adalimumab, and ESBA105.
Lichtlen P; Lam TT; Nork TM; Streit T; Urech DM
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4738-45. PubMed ID: 20393113
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of the novel small-molecule integrin alpha5beta1 inhibitor JSM6427 in monkey and rabbit models of choroidal neovascularization.
Zahn G; Vossmeyer D; Stragies R; Wills M; Wong CG; Löffler KU; Adamis AP; Knolle J
Arch Ophthalmol; 2009 Oct; 127(10):1329-35. PubMed ID: 19822850
[TBL] [Abstract][Full Text] [Related]
11. Anti-angiogenic effect of KR-31831 on corneal and choroidal neovascularization in rat models.
Kim IT; Park HY; Choi JS; Joo CK
Invest Ophthalmol Vis Sci; 2012 May; 53(6):3111-9. PubMed ID: 22491414
[TBL] [Abstract][Full Text] [Related]
12. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.
Krzystolik MG; Afshari MA; Adamis AP; Gaudreault J; Gragoudas ES; Michaud NA; Li W; Connolly E; O'Neill CA; Miller JW
Arch Ophthalmol; 2002 Mar; 120(3):338-46. PubMed ID: 11879138
[TBL] [Abstract][Full Text] [Related]
13. Clinical and histological findings after intravitreal injection of bevacizumab (Avastin) in a porcine model of choroidal neovascularization.
Lassota N; Prause JU; Scherfig E; Kiilgaard JF; la Cour M
Acta Ophthalmol; 2010 May; 88(3):300-8. PubMed ID: 19416113
[TBL] [Abstract][Full Text] [Related]
14. Treatment of choroidal neovascularization using intravitreal bevacizumab.
Pedersen R; Soliman W; Lund-Andersen H; Larsen M
Acta Ophthalmol Scand; 2007 Aug; 85(5):526-33. PubMed ID: 17511757
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.
Husain D; Kim I; Gauthier D; Lane AM; Tsilimbaris MK; Ezra E; Connolly EJ; Michaud N; Gragoudas ES; O'Neill CA; Beyer JC; Miller JW
Arch Ophthalmol; 2005 Apr; 123(4):509-16. PubMed ID: 15824225
[TBL] [Abstract][Full Text] [Related]
16. The effect of subconjuctival combined treatment of bevacizumab and triamcinolone acetonide on corneal neovascularization in rabbits.
Kang S; Chung SK
Cornea; 2010 Feb; 29(2):192-6. PubMed ID: 20098156
[TBL] [Abstract][Full Text] [Related]
17. Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration.
Lazic R; Gabric N
Graefes Arch Clin Exp Ophthalmol; 2007 Jan; 245(1):68-73. PubMed ID: 17111146
[TBL] [Abstract][Full Text] [Related]
18. Molecular biology of choroidal neovascularization.
Lu M; Adamis AP
Ophthalmol Clin North Am; 2006 Sep; 19(3):323-34. PubMed ID: 16935207
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.
Ladas ID; Kotsolis AI; Papakostas TD; Rouvas AA; Karagiannis DA; Vergados I
Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin.
Chan WM; Lai TY; Liu DT; Lam DS
Am J Ophthalmol; 2007 Jun; 143(6):977-983. PubMed ID: 17459318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
